...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor
【24h】

Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor

机译:术前类固醇使用以及围手术期并发症的发生率,患者接受了颅脑肿瘤的明确切除

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We studied the impact of preoperative steroids on 30 day morbidity and mortality of craniotomy for definitive resection of malignant brain tumors. Glucocorticoids are used to treat peritumoral edema in patients with malignant brain tumors, however, prolonged (>= 10 days) use of preoperative steroids as a risk factor for perioperative complications following resection of brain tumors has not been studied comprehensively. Therefore, we identified 4407 patients who underwent craniotomy to resect a malignant brain tumor between 2007 and 2012, who were reported in the National Surgical Quality Improvement Program, a prospectively collected clinical database. Metastatic brain tumors constituted 37.5% (n = 1611) and primary malignant gliomas 62.5% (n = 2796) of the study population. We used logistic regression to assess the association between preoperative steroid use and perioperative complications before and after 1:1 propensity score matching. Patients who received steroids constituted 22.8% of the population (n = 1009). In the unmatched cohort, steroid use was associated with decreased length of hospitalization (odds ratio [OR] 0.7; 95% confidence interval [CI] 0.6-0.8), however, the risk for readmission (OR 1.5; 95% CI 1.2-1.8) was increased. In the propensity score matched cohort (n = 465), steroid use was not statistically associated with any adverse outcomes. Patients who received steroids were less likely to stay hospitalized for a protracted period of time, but were more likely to be readmitted after discharge following craniotomy. As an independent risk factor, preoperative steroid use was not associated with any observed perioperative complications. The findings of this study suggest that preoperative steroids do not independently compromise the short term outcome of craniotomy for resection of malignant brain tumors. (C) 2015 Elsevier Ltd. All rights reserved.
机译:我们研究了术前类固醇对30天发病率的影响,颅骨术治疗恶性脑肿瘤的过敏。糖皮质激素用于治疗恶性脑肿瘤的患者患有腹腔水肿,然而,延长(> = 10天)术前类固醇作为脑肿瘤切除后术后并发症的危险因素尚未得到全面研究。因此,我们确定了4407名患者,在2007年至2012年期间,在2007年至2012年间,在国家外科质量改进计划中报告了一项预期收集的临床数据库。转移性脑肿瘤构成了37.5%(n = 1611)和研究人群的主要恶性胶质瘤62.5%(n = 2796)。我们使用Logistic回归来评估术前类固醇使用与1:1之后的术前类固醇使用和围手术期并发症之间的关联。接受类固醇的患者构成22.8%的人口(n = 1009)。在无与伦比的队列中,类固醇使用与住院时间减少有关(差距[或] 0.7; 95%置信区间[CI] 0.6-0.8),但入院风险(或1.5; 95%CI 1.2-1.8 )增加了。在倾向得分匹配队列(n = 465)中,类固醇使用与任何不利结果没有统计学相关。接受类固醇的患者不太可能在长期的时间内住院,但在Craniotomy后放电后更有可能被预留。作为一种独立的危险因素,术前类固醇使用与任何观察到的围手术期并发症无关。本研究的结果表明,术前类固醇并未独立地损害Craniotomy的短期结果,用于切除恶性脑肿瘤。 (c)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号